Strategic Initiative

Slingshot members are tracking this corporate initiative:

ImmunoGen (IMGN) and Merck (MRK) Announce Research Collaboration to Evaluate IMGN's Mirvetuximab Soravtansine with Keytruda in Folate Receptor Alpha-Positive Ovarian Cancer

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
High Medium Low
Impact on Stocks


Slingshot Insights Explained
Strategic Initiative Date
Announcement Date:
Feb 04, 2016
Relevance Tracked Until:
Q1, 2017
Related Projects Image
  • Don’t see a project related to the strategic initiative you care about?

Related Keywords Research Collaboartion, Mirvetuximab Soratansine, Keytruda, Folate Receptor, Alpha-positive, Ovarian Cancer, Phase 1b/2 Forward Ii Trial